Clinical TrialsSearch results
Number of results: 1471
Other
- Cancer therapy with vaccination using HLA-A02 restricted peptide from human vascular endothelial growth factor receptor 2: a phase I study patients with unresectable colorectal cancer
- unresectable colorectal cancer
- Institute of Medical Science, University of Tokyo
- 2007-05-02
Other
- Cancer therapy with vaccination using HLA-A02-restricted peptide from RNF43: a phase I study in patients with unresectable colorectal cancer
- unresectable colorectal cancer
- Institute of Medical Science The University of Tokyo
- 2007-05-10
Other
- Cancer therapy with vaccination using HLA-A24-restricted peptide from human vascular endothelial growth factor receptor 2: a phase I study in patients with unresectable colorectal cancer
- unresectable colorectal cancer
- Institute of Medical Science, University of Tokyo
- 2007-05-02
Other
- Cancer therapy with vaccination using HLA-A24-restricted peptide from RNF43:a phase I study in patients with unresectable colorectal cancer
- unresectable colorectal cancer
- Institute of Medical Science, University of Tokyo
- 2007-05-07
Other
- Cancer therapy with vaccination using HLA-A24-restricted peptide from TOMM34:a phase I study in patients with unresectable colorectal cancer
- unresectable colorectal cancer
- Institute of Medical Science, University of Tokyo
- 2007-07-30
Other
- Phase I clinical trial of epitope peptides based vaccines both targeting RNF43 and VEGFR2 in patients with advanced colorectal cancer.
- unresectable colorectal cancer
- Institute of Medical Science The University of Tokyo
- 2007-12-23
Recruiting
- ONO-4578-02:ONO-4578 Phase 1 Study
- Unresectable colorectal cancer
- Hirashima Yoshinori
- 2020-11-25
Not yet recruiting
- Correlation between prognosis and expressions of Mcl-1(Myeloid cell leukemia-1) and Stat-3(signal transducers and activator of transcription-3) in patients with metastasized or recurrent gastrointestinal malignancy
- Unresectable and recurrent gastric or colorectal carcinoma
- Keio University School of Medicine
- 2008-11-01
Other
- Phase II study of Bevacizumab plus modified OPTIMOX1 in patients with unresectable advanced/recurrent colorectal cancer
- Unresectable advanced/recurrent colorectal cancer
- The Tokyo Cooperative Oncology Group
- 2008-06-01
Other
- Phase2/3 Study of OTS102 in Combination With Gemcitabine in Patients With Unresectable Advanced Pancreatic Cancer and Recurrent Pancreatic Cancer(PEGASUS-PC Study)
- Unresectable Advanced and Recurrent Pancreatic Cancer
- OncoTherapy Science, Inc.
- 2009-01-27